Fritextsökning
Artiklar per år
Innehållstyper
-
Superdator ska bekämpa folksjukdomar
Ett nytt kraftfullt forskningsverktyg för beräkning och lagring av data ska hjälpa svenska forskare att hitta fler mutationer som orsakar sjukdomar.
-
Messa frysen om läget
Asper Systems lanserar en ny generation övervakningssystem som kan kontakta upp till fem telefonnummer om något är fel.
-
Mycket på gång i Moberg Derma
Bolaget har tecknat avtal kring en teknologiplattform för att spreja på läkemedel. Ett licensavtal med ett av Sveriges största hudvårdsbolag ska leda till en ny behandling mot nagelsvamp, och i höst lanseras en helt ny produktserie.
-
Bygger biobank i världsklass
Danska Statens Serum Institut får 121 miljoner för att bygga upp en av världens bästa biobanker.
-
Genjägare får ny vd
Det norska tjänsteföretaget Hunt Biosciences har utsett en ny vd.
-
Ny modell minskar risken med Waran
Nu kan läkarna räkna fram rätt dos av det blodförtunnande medlet Waran. Tack vare en modell från Uppsala universitet.
-
Forskningsstöd missgynnar kvinnor
Fler män får stöd, och de får i genomsnitt mer pengar. De danska forskningsrådens sätt att fördela pengar förstärker könsskillnaderna i forskningsvärlden, enligt en ny rapport.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.
BREAKING